| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8922477 | Clinical and Translational Radiation Oncology | 2017 | 4 Pages |
Abstract
SBRT was feasible for approximately half of the locally-advanced NSCLC patients we assessed and for these patients has the potential to reduce a 30 fraction course to 12 fractions. Using SBRT in this setting requires compromises in techniques and further compromises may allow SBRT in a greater proportion of patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Katrina Woodford, Vanessa Panettieri, Trieumy Tran Le, Sashendra Senthi,